US expansion Neko Health is actively expanding into the United States with its first flagship clinic in Manhattan SoHo and plans for San Francisco and Boston in early 2027, indicating a large potential enterprise customer base and regional growth opportunities for partnerships, equipment procurement, and enterprise wellness programs.

Massive demand The company has generated significant inbound interest, exemplified by more than 50,000 people on the NYC waitlist just weeks after launching the first US clinic, signaling strong market appetite for proactive, preventive health scanning services that can be scaled with additional clinics, telehealth integration, or corporate health programs.

Strategic funding Recent Series B financing of about €2.5 million from Flight Fund alongside a $2.8 million follow-on indicates strong investor confidence and capital availability to accelerate sales efforts, enterprise partnerships, and expansion initiatives in the US market.

Competitive landscape The market faces competition from low-cost lab-first models and MRI-based players, suggesting opportunities for Neko to differentiate through integrated care pathways, clinically validated value propositions, and partnerships with health systems or employers seeking comprehensive preventive care for their populations.

Cross-border potential As a European unicorn in longevity and preventive care, Neko can pursue cross-border enterprise deals with multinational corporations, health insurers, and corporate wellness programs leveraging its scalable preventive scanning platform and potential data-enabled health insights to reduce long-term healthcare costs.